Journal of Heterocyclic Chemistry p. 649 - 652 (1997)
Update date:2022-08-05
Topics:
Moniz, George A.
Hammond, Gerald B.
Aminoglutethimide [3-(4-aminophenyl)-3-ethylpiperidine-2,6-dione] has been used clinically in the treatment of metastatic breast carcinoma. Inhibition of tumor growth is due to interference with estrogen biosynthesis. However, its action is not specific and its metabolism gives rise to toxic and non-inhibitory metabolites. We sought to explore the impact of relocating the amino group in aminoglutethimide to the ethyl side chain. To that end, we now report the synthesis and aromatase-inhibitory activity of 3-(2′-N,N-diethylamino)ethyl-3-phenylpiperidine-2,6-dione 5. The introduction of the amino functionality on the ethyl group is accomplished via reductive amination of aldehyde 8, prepared in three steps from benzyl cyanide, The synthetic route presented can be used for the preparation of related derivatives of azninoglutethimide.
View MoreZHEJIANG CHEMICAL INDUSTRY INSTITUTE TECHNOLOGY CO.,LTD(expird)
Contact:86-575-82730298
Address:shangyu
Contact:+86-579-85206992
Address:No 451 chouzhou north road ,room 1106 int'l business center , yiwu ,china
Zhangjiagang Jianing Import & Export Co.,Ltd.
Contact:086-512-55379012 13913607595
Address:NO.1 Guotai North Road Zhangjiagang Economic Development Zone,215600,Jiangsu,China
Onlychem (Jinan)Biotech Co.,Ltd
Contact:86-531-83175885
Address:No. 44, Honglou South Road, Jinan,China
Contact:0086 533 2282832
Address:Zibo,Shandong
Doi:10.1021/jm960850i
(1997)Doi:10.1016/S0960-894X(97)00245-X
(1997)Doi:10.1021/jo01258a049
(1969)Doi:10.1002/hlca.19970800304
(1997)Doi:10.1016/S0040-4039(97)00777-6
(1997)Doi:10.1139/v68-306
(1968)